未登录
分享
收藏
分享
收藏
分享
收藏PPAR-γ agonist pioglitazone and the risks of malignancy among type2 diabetes mellitus patients
See, Lai-Chu; Wu, Chao-Yi; Tsai, Chung-Ying; Lee, Cheng-Chia; Chen, Jia-Jin; Jenq, Chang-Chyi; Chen, Chao-Yu; Chen, Yung-Chang; Yen, Chieh-Li; Yang, Huang-Yu
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏Cardiovascular, renal, and lower limb outcomes in patients with type 2 diabetes after percutaneous coronary intervention and treated with sodium-glucose cotransporter 2 inhibitors vs. dipeptidyl peptidase-4 inhibitors
Lee, Hsin-Fu; Chan, Yi-Hsin; Chuang, Chi; Li, Pei-Ru; Yeh, Yung-Hsin; Hsiao, Fu-Chih; Peng, Jian-Rong; See, Lai-Chu
分享
收藏
分享
收藏
分享
收藏